Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3337 Target Snapshot

Vascular endothelial growth factor receptor 2 · SINGLE PROTEIN · Mus musculus

133Compounds
21Assays
6Approved Drugs
137.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P35918. Use UniProt P35918 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P35918 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Vascular endothelial growth factor receptor 2 as ChEMBL target CHEMBL3337, mapped to UniProt P35918. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Vascular endothelial growth factor receptor 2
SINGLE PROTEIN · Mus musculus
As of 2026-09-14
ChEMBL target ID
CHEMBL3337
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P35918
Vascular endothelial growth factor receptor 2
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Vascular endothelial growth factor receptor 2 is the right protein anchor across sources, using UniProt P35918 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelVascular endothelial growth factor receptor 2
UniProt AccessionP35918
Component TypeProtein
Sequence Length1345 aa

Vascular endothelial growth factor receptor 2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Vascular endothelial growth factor receptor 2, mapped to UniProt P35918. Sequence length is 1345 aa.

Mapped IDP35918
Review nameVascular endothelial growth factor receptor 2
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

6
Approved
4
Phase III
1
Phase II
Assay Mix

Activity Type Distribution

IC50136.0
KI1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3545376 10.0 IC50 0.1 Approved
CHEMBL205893 9.0 IC50 1.0 Preclinical
CHEMBL1946170 8.82 IC50 1.5 Approved
CHEMBL205108 8.7 IC50 2.0 Preclinical
CHEMBL383618 8.52 IC50 3.0 Preclinical
CHEMBL204426 8.4 IC50 4.0 Preclinical
CHEMBL378024 8.3 IC50 5.0 Preclinical
CHEMBL572881 8.22 IC50 6.0 Clinical
CHEMBL380702 8.1 IC50 8.0 Preclinical
CHEMBL269924 8.0 IC50 10.0 Preclinical
Distribution

pChEMBL Value Distribution

13
5.0
17
5.5
12
6.0
17
6.5
19
7.0
15
7.5
8
8.0
3
8.5
1
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

ERDAFITINIB
CHEMBL3545376
Approved 2019
NINTEDANIB ESYLATE
CHEMBL3039504
Approved 2014
NINTEDANIB
CHEMBL502835
Approved 2014
REGORAFENIB
CHEMBL1946170
Approved 2012
SUNITINIB
CHEMBL535
Approved 2006
SORAFENIB
CHEMBL1336
Approved 2005
Assay Landscape

Assay Landscape

21
Total Assays
123
Tested Compounds
1
Assay Types
Binding — 21 assays, 123 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 14 100 6.5
cell-based format 6 15 7.0
assay format 1 8 6.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine